Stock Price Quote

VENKY'S (INDIA) LTD.

NSE : VENKEYSBSE : 523261ISIN CODE : INE398A01010Industry : AgricultureHouse : Private
BSE1989.65-52.8 (-2.59 %)
PREV CLOSE ( ) 2042.45
OPEN PRICE ( ) 2099.90
BID PRICE (QTY) 1989.40 (1)
OFFER PRICE (QTY) 1993.70 (6)
VOLUME 12554
TODAY'S LOW / HIGH ( )1975.00 2106.00
52 WK LOW / HIGH ( )1530 2312.95
NSE1993.95-48.45 (-2.37 %)
PREV CLOSE( ) 2042.40
OPEN PRICE ( ) 2087.00
BID PRICE (QTY) 1992.05 (2)
OFFER PRICE (QTY) 1993.95 (66)
VOLUME 103515
TODAY'S LOW / HIGH( ) 1974.55 2110.00
52 WK LOW / HIGH ( )1531 2314.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 01-07 1976
Management Info
Anuradha J Desai - Chairman B Balaji Rao - Managing Director
Registered Office

Address Venkateshwara House,S No 114 / A / 2,Pune - Sinhagad Road,
Pune,
Maharashtra-411030

Phone 020-24251530-41

Email corp.shares@venkys.com

Website www.venkys.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

15Jun Venky's (India) informs about issue of
Venky's (India) has informed that company has received enclosed request..
13Jun Venky's (India) informs about details
Pursuant to Regulation 39 of the SEBI (Listing Obligations and Disclosur..
28May Venky's (India) informs about annual s
Pursuant SEBI Circular no. CIR/CFD/CMD1/27/2019 dated February 08, 2019,..
20Mar Venky's (India) gains on starting comm
Venky'S (India) is currently trading at Rs. 1606.30, up by 24.65 points..
19Mar Venky's (India) starts commercial prod
Venky's (India) has started commercial production of Veterinary Medicine..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit335.099999999999790.700000000007
Gross Profit 474.499999999999 1094.20000000001
Operating Profit 608.6999999999991626.00000000001
Net Sales 8959.437381.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kaveri Seed (BSE)
peergroup  971.90 (3.93%)
M.Cap ( in Cr)5007.85
Bombay Burmah Trdg. (BSE)
peergroup  1631.00 (0.58%)
M.Cap ( in Cr)11463.52
Nath Bio-Genes (BSE)
peergroup  208.70 (4.32%)
M.Cap ( in Cr)396.80
Indo US Bio-Tech (BSE)
peergroup  231.00 (2.64%)
M.Cap ( in Cr)471.22
Agri-Tech (India) (BSE)
peergroup  203.05 (2.60%)
M.Cap ( in Cr)123.55

Shareholding Pattern

PROMOTERS 56.11%
NON-INSTITUTION 42.43%
MUTUAL FUNDS/UTI 0.06%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Venky'S (India) Ltd.

Venky'S (India) Ltd. was incorporated in the year 1976. Its today's share price is 1989.65. Its current market capitalisation stands at Rs 2829.93 Cr. In the latest quarter, company has reported Gross Sales of Rs. 42336.85 Cr and Total Income of Rs.42713.54 Cr. The company's management includes Rohan Ajay Bhagwat, Uttara J Desai, Jitendra M Desai, Ashutosh Nargolkar, P Neeraja, Amrit Kapur, Rajeshwar Singh, Ashok Mahajan, B Balaji Rao, B Venkatesh Rao, Anuradha J Desai.

It is listed on the BSE with a BSE Code of 523261 , NSE with an NSE Symbol of VENKEYS and ISIN of INE398A01010. It's Registered office is at Venkateshwara House,S No 114 / A / 2,Pune - Sinhagad RoadPune-411030, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BD Jokhakar & Co, Sudit K Parekh & Co, Sudit K Parekh & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.